An exclusive Q&A with Bill Sarraille, Senior Partner with Sidley’s Health Care Practice.
WATCH THE VIDEO PREVIEW
DOWNLOAD THE FULL 6-PAGE Q&A TRANSCRIPT
Bill Sarraille discusses the widespread concerns regarding comparative effectiveness and its potential impact on the medical device industry. According to Sarraille, "We’re going to be in a situation where companies will have to think long and hard about the strategic and tactical decisions around what kind of research to do and how to do it, because in an age where there is transparency about clinical trial research, the reality is that the kinds of research that companies will be doing from a comparative effectiveness perspective will be very public." He added, "If companies don’t conduct comparative effectiveness research in a careful way, a thoughtful way, it’s quite possible that they could develop evidence that would be very contrary to their interests."
Bill Sarraille shared his insights with Medical Devices Today about:
- The new challenges comparative effectiveness are likely to create for the medical device industry, including some pitfalls to be on the lookout for.
- The risks that comparative effectiveness will create for the health care industry as a whole.
- The international implications of comparative effectiveness and the lessons we have already learned about it from its use in Europe and Great Britain.
-
Click here to download the exclusive 6-page Q&A with Bill Sarraille
Related Reading:
- Comparative Effectiveness Researchers Look Beyond Randomized Trials – June 8, 2009 – “The Gray Sheet”
- HHS Seeks Weigh-In On Broadly Defined Comparative Effectiveness Criteria – June 8, 2009 – “The Gray Sheet”
- CER Draft Definition Raises No Red Flags, But More Clarity Sought - June 1, 2009 – “The Pink Sheet”
- Cost-Cutting Sequel Yields Little Surprise: PhRMA Supports Efficient Medication Use, More Drug Development, Expanded Access - June 1, 2009 - “The Pink Sheet” DAILY
- Comparative Effectiveness Bill Allows Industry Input Into Study Selection – May 25, 2009 – “The Gray Sheet”
- Baucus Opposes Linking Comparative Effectiveness Research To Coverage – May 18, 2009 – “The Gray Sheet”
- Senate Adding Safeguards Against Direct Link Between Comparative Effectiveness Research, Coverage Decisions – May 13, 2009 - “The Pink Sheet” DAILY
- De-linking Coverage from Comparative Effectiveness Research – May 1, 2009 – The RPM Report
- Health Care Reforms Target Medical Devices – May 1, 2009 – IN Vivo
On The Record is new feature from Medical Devices Today featuring topical Q&A's with industry thought leaders. For more information, please contact Sean Smith at se.smith@elsevier.com.
